Skip to main content
Log in

A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Sixteen patients with uncomplicated hypertension were studied in a double-blind within-patient trial comparing slow release oxprenolol (SRO) with conventional oxprenolol (CO). The antihypertensive effect of SRO once daily was greater than that of CO once daily, although this did not reach statistical significance. CO once daily was less effective than CObd and this difference was statistically significant for lying diastolic blood pressure. After exercise testing 26 hours post-dose, blood pressure and pulse rate were marginally lower on SRO than on CO, but this difference was not significant. Blood pressure readings 24 h post-dose were lower following morning dosing than following evening dosing, although pulse rates showed the opposite trend.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gatley, M. S.: To be taken as directed. J. R. Coll. Gen. Pract.16, 39 (1968)

    Google Scholar 

  2. Davidson, C., Thadani, U., Taylor, S. H., Hess, H., Riess, W.: Pharmacological Studies with slow-release formulations of oxprenolol in man. Europ. J. clin. Pharmacol.10, 189–195 (1976)

    Google Scholar 

  3. Brunner, L., Imhof, P., Jack, D.: Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man. Europ. J. clin. Pharmacol.8, 3–9 (1975)

    Google Scholar 

  4. West, M. J., Kendall, M. J., Mitchard, M. (1976): A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects. Br. J. Clin. Pharmacol.3, 439 (1976)

    Google Scholar 

  5. Mason, W. D., Winer, N.: Pharmacokinetics of oxprenolol in normal subjects. Clin. Pharmacol. Ther.20, 401 (1976)

    Google Scholar 

  6. Simpson, F. O., Waal-Manning, H. J.: Hypertension and beta-adrenergic blockade, IN New Horizons in Medicine I, Symposium on Beta-Adrenergic Blockade, Sydney, Australia, February 1970, pp 59–72. Basel: Sandoz 1970

    Google Scholar 

  7. Waal-Manning, H. J.: Metabolic effects of beta-adrenoreceptor blocker. Drugs II (Suppl. i) 121–126. ADIS Press 1976

  8. Ibsen, H., Sederberg-Olsen, P.: Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin. Sci.44, 129–134 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Resnekov, E.B., Havard, C.W.H. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension. Eur J Clin Pharmacol 14, 77–81 (1978). https://doi.org/10.1007/BF00607434

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00607434

Key words

Navigation